# Samyang Biopharm Corporation (0120G0.KS): MoatMap facts

As of 20 Oct 2026. Research data, not investment advice.

As of 20 Oct 2026, MoatMap's StockRank for Samyang Biopharm Corporation (0120G0.KS) is 3/100, ranked against 24,000+ stocks in 35 markets (Quality 26, Value 23, Momentum 16, each scored against its sector).

- StockRank: 3/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 26, Value 23, Momentum 16: each a 0-100 percentile within the stock's sector.
- Position: #26,223 overall, #2,568 in Healthcare.
- Listing: South Korea, KSC; Healthcare / Medical Devices.
- Last close: 44,900 KRW on 19 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/0120G0.KS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker